ABIO Average Annual Return 10 Years

Growth of $10,000.00
With Dividends Reinvested Into ABIO

Also see:
• ABIO stock yearly return 2014
• ABIO stock yearly return 2015
• ABIO stock yearly return 2016
• ABIO stock yearly return 2017
• ABIO stock yearly return 2018
• ABIO stock yearly return 2019
• ABIO stock yearly return 2020
• ABIO stock yearly return 2021
• ABIO stock yearly return 2022
• ABIO stock yearly return 2023
• ABIO YTD return

Compare ABIO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	09/03/2014
End date:	08/30/2024
Start price/share:	$167.58
End price/share:	$2.40
Starting shares:	59.67
Ending shares:	98.17
Dividends reinvested/share:	$1.61
Total return:	-97.64%
ABIO Average Annual Return:	-31.27%
Starting investment:	$10,000.00
Ending investment:	$235.46

ABIO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. The ABIO average annual return 10 years is shown above.

The Average Annual Return on the ABIO average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ABIO average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ABIO average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free ABIO Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Oruka Therapeutics (ABIO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ABOS Average Annual Return
ABSI Average Annual Return
ABT Average Annual Return
ABVC Average Annual Return
ACAD Average Annual Return
ACCD Average Annual Return
ACET Average Annual Return
ACHC Average Annual Return
ACHV Average Annual Return
ACLX Average Annual Return
More Healthcare companies »

What has the average annual return been for ABIO over the past ten years?

✔️Accepted answer: The ten year ABIO average annual return has been -31.27% with dividends reinvested.

When you say 'with dividends reinvested' what does that mean?

✔️Accepted answer: That means that each time the stock goes ex-dividend, the average annual return calculation then factors in how that dividend amount could have been reinvested into more shares of ABIO at the then-current price — often this is referred to as 'compounding' and is very important when considering average annual return over a long period like a full decade.

What start date was used in your ABIO average annual return calculation?

✔️Accepted answer: The start date was 09/03/2014.

What end date was used in your ABIO average annual return calculation?

✔️Accepted answer: The end date was 08/30/2024.

If I had invested $10,000 into ABIO ten years ago, how much would I have today?

✔️Accepted answer: With dividends reinvested, as of 08/30/2024, you would have $235.46.

What does that work out to on a total return basis?

✔️Accepted answer: The ABIO ten year total return ending 08/30/2024 works out to -97.64%.

ABIO Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved